PATCH 2&3:Prevention & Treatment of COVID-19 (Severe Acute Respiratory Syndrome Coronavirus 2) With Hydroxychloroquine

Stopped As enrollment began external studies called into question the safety and efficacy of hydroxychloroquine as a treatment which resulted in controversy. The timing of the controversy significantly impacted our ability to enroll and retain participants.

Conditions

• Coronavirus
• Corona Virus Infection

Interventions

• DRUG: Group 1 HCQ
• DRUG: Group 2 Placebo

Sponsor

UnitedHealth Group

Collaborators

• [object Object]
• [object Object]